The present disclosure relates to a system and/or method of growing cells in a cell expansion system (CES), and more particularly, a method of loading and distributing cells in a bioreactor of a CES.
CESs are used to expand and differentiate cells. Cell expansion systems are known in the art. For example, U.S. Pat. Nos. 5,162,225 and 6,001,585 generally describe cell expansion systems designed for cell expansion.
The potential use of stem cells in a variety of treatments and therapies has achieved particular attention. Cell expansion systems can be used to grow stem cells, as well as other types of cells, such as bone marrow cells. Stem cells which are expanded from donor cells can be used to repair or replace damaged or defective tissues and have broad clinical applications for a wide range of diseases. Recent advances in the regenerative medicine field demonstrates that stem cells have properties such as proliferation and self-renewal capacity, maintenance of the unspecialized state, and the ability to differentiate into specialized cells under particular conditions.
Cell expansion systems include one or more compartments for growing the cells, such as a cell growth chamber, also referred to herein as a “bioreactor.” However, a CES with a stationary bioreactor may limit the production of cells as compared to a system that provides some ability to adjust the position of the bioreactor. For example, the influence of gravity may impede the distribution of cells when first introducing the cells into the bioreactor (also referred to herein as “loading”), and thus the subsequent expansion of cells in the bioreactor. Accordingly, there is a need for a method of loading and distributing cells in a bioreactor associated with a cell expansion system. The present disclosure addresses this and other needs.
It is to be understood that the present invention includes a variety of different versions or embodiments, and this Summary is not meant to be limiting or all-inclusive. This Summary provides some general descriptions of some of the embodiments, but may also include some more specific descriptions of other embodiments.
One or more embodiments are generally directed to a method and system for loading and distributing cells in a bioreactor of a cell expansion system. Accordingly, a method of loading and distributing a plurality of cells in a cell expansion system is provided, the method comprising:
providing a bioreactor;
orienting the bioreactor in a first orientation; and
loading the plurality of cells within the bioreactor while:
One or more embodiments of the present invention are directed to a multi-phase method of distributing a plurality of cells in a bioreactor of a cell expansion system. Accordingly, a multi-phase timing method of distributing a plurality of cells loaded into a bioreactor of a cell expansion system is provided, the multi-phase timing method comprising:
a first phase comprising rotating the bioreactor about an axis for a first period of time and through a first angular displacement;
a second phase comprising holding the bioreactor still for a second period of time;
a third phase comprising rotating the bioreactor about the axis for a third period of time and through a second angular displacement, wherein the third period of time is substantially equal to the first period of time, and wherein the second angular displacement is substantially equal to the first angular displacement; and
a fourth phase comprising holding the bioreactor still for a fourth period of time, wherein the fourth period of time is substantially equal to the second period of time.
In at least one embodiment the second period of time is substantially equal to 2ω−1, where ω is an angular velocity (rad/sec) of the bioreactor when rotating the bioreactor during the first phase. In at least one embodiment the first angular displacement is approximately 270°.
In addition to the foregoing, a method of distributing a plurality of cells loaded into a bioreactor of a cell expansion system is provided, the method comprising:
(a) rotating the bioreactor at an angular velocity ω about an axis of rotation and through a first angular displacement θ1, the bioreactor rotating from a first orientation to a second orientation;
(b) holding the bioreactor still at the second orientation for a first period of time t1, wherein t1 substantially equals 2/ω;
(c) rotating the bioreactor at the angular velocity ω about the axis of rotation and through a second angular displacement θ2; and
(d) holding the bioreactor still for a second period of time t2, wherein t2 substantially equals t1;
wherein step (a) comes at least before step (b), wherein step (b) comes at least before step (c), and wherein step (c) comes at least before step (d). In at least one embodiment the first angular displacement θ1 equals approximately 270°. In at least one embodiment a total angular displacement associated with steps (a) and (c) is about 540°.
One or more embodiments of the present invention are directed at manipulating the bioreactor to mitigate the influence of gravity on the distribution of cells in the bioreactor. Accordingly, a method of distributing a plurality of cells in a bioreactor of a cell expansion system is provided, comprising: manipulating an orientation of the bioreactor such that a net impulse due to gravity acting on the plurality cells in the bioreactor is substantially zero. In at least one embodiment said manipulating comprises rotating the bioreactor at a first angular velocity. In at least one embodiment said manipulating further comprises holding the bioreactor substantially stationary for a first period of time t1. In at least one embodiment the first period of time t1 is approximately equal to 2 divided by the first angular velocity (rad/sec). In at least one embodiment said manipulating comprises rotating the bioreactor, and the rotating includes using a plurality of angular velocities. In at least one embodiment said manipulating comprises holding the bioreactor substantially stationary for a period of time tp equal to 2 divided by the first angular velocity (rad/sec). In at least one embodiment a total angular displacement associated with the manipulating is about 540°.
In at least one embodiment, a method of distributing a plurality of cells in a bioreactor of a cell expansion system is provided, the method comprising: reducing a net impulse due to gravity acting on the plurality of cells by manipulating an orientation of the bioreactor. In addition to the foregoing embodiments noted above, in at least one embodiment said manipulating comprises rotating the bioreactor around at least a first axis of rotation. In at least one embodiment said first axis of rotation is substantially perpendicular to a longitudinal axis LA-LA of the bioreactor. In at least one embodiment said first axis of rotation is substantially coincident with a longitudinal axis LA-LA of the bioreactor.
As used herein, “at least one,” “one or more,” and “and/or” are open-ended expressions that are both conjunctive and disjunctive in operation. For example, each of the expressions “at least one of A, B and C,” “at least one of A, B, or C,” “one or more of A, B, and C,” “one or more of A, B, or C” and “A, B, and/or C” means A alone, B alone, C alone, A and B together, A and C together, B and C together, or A, B and C together.
Various embodiments of the present inventions are set forth in the attached figures and in the Detailed Description as provided herein and as embodied by the claims. It should be understood, however, that this Summary does not contain all of the aspects and embodiments of the one or more present inventions, is not meant to be limiting or restrictive in any manner, and that the invention(s) as disclosed herein is/are and is understood by those of ordinary skill in the art to encompass obvious improvements and modifications thereto.
Additional advantages of the embodiments presented herein will become readily apparent from the following discussion, particularly when taken together with the accompanying drawings.
To further clarify the above and other advantages and features of the present invention, a more particular description of the invention will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. The invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
The drawings are not necessarily to scale.
The present disclosure is generally directed to a method for distributing a plurality of cells in a bioreactor of a cell expansion system. As described below, a method of distributing cells within a bioreactor may include loading cells into the bioreactor, rotating the bioreactor, and holding the bioreactor still at certain orientations.
With reference now to
Fluid in a first circulation path enters bioreactor 100 through IC inlet port 108 at a first longitudinal end 112 of the bioreactor 100, passes into and through the intracapillary side (referred to in various embodiments as the intracapillary (“IC”) side or “IC space” of a hollow fiber membrane) of a plurality of hollow fibers 116, and out of bioreactor 100 through IC outlet port 120 located at a second longitudinal end 124 of the bioreactor 100. Fluid in a second circulation path flows in the bioreactor 100 through EC inlet port 128, comes in contact with the extracapillary side or outside (referred to as the “EC side” or “EC space” of the membrane) of the hollow fibers 116, and exits bioreactor 100 via EC outlet port 132. Fluid entering bioreactor via an EC inlet port 128 is in contact with the outside of the hollow fibers. Small molecules (e.g. water, oxygen, lactate, etc.) can diffuse through the hollow fibers from the interior of the hollow fiber to the EC space, or from the EC space to the IC space. Large molecular weight molecules such as growth factors are typically too large to pass through the hollow fibers, and remain in the IC space of the hollow fibers. The media may be replaced as needed. Media may also be circulated through an oxygenator to exchange gasses as needed. Cells can be contained within the first circulation path and/or second circulation path, and can be on either the IC side and/or EC side of the membrane. By way of example and not limitation, specifications for an exemplary bioreactor for use in a cell expansion system are provided in the following table:
Although bioreactor housing 104 is depicted as cylindrical in shape, it could have a variety of shapes, such as a rectangular cube. Bioreactor housing 104 can be made of any type of biocompatible polymeric material, including a substantially transparent material that permits an observer to see one or more of the plurality of hollow fibers 116, as well as fluid residing within the bioreactor housing 104. Various other bioreactor housings may differ in shape and size.
Referring now to
Referring now to
With further reference to the flow chart of
In at least one embodiment, cells may be loaded into the IC side of the bioreactor 100 (or into the hollow fibers 116 of the bioreactor 100) by causing flow of a media carrying the cells to pass from the IC inlet 108 to the EC outlet 132. In addition, cells may be loaded into the EC side of the bioreactor 100 (or to the exterior of the hollow fibers 116 of the bioreactor 100) by causing flow of a media carrying the cells to pass from the EC inlet 128 to the IC outlet 120.
To assist with determining the desired movements of the bioreactor 100 to facilitate improved distribution of cells within the bioreactor 100, a series of calculations were performed to calculate a basis for positioning the bioreactor 100. More particularly, by rotating the bioreactor 100, the influence of the acceleration due to gravity on a given cell (e.g., bone marrow cell) within the bioreactor 100 can be affected relative to the geometry of the bioreactor 100. To achieve a net impulse of zero on the cell, calculation of the impulse (“I”) is performed to determine the change during rotation and counteract the impulse with the appropriate pause time at 0° and 270°.
To start, initial consideration is given to the acceleration experienced by a cell within the bioreactor 100. As a premise of the present invention, it is desirable to counteract the acceleration due to gravity (“g”) on a given cell in the bioreactor 100 associated with distributing cells in the bioreactor 100. Accordingly, a rotation sequence for the bioreactor 100 is sought to achieve a net gravitational influence on a given cell of zero associated with loading and distributing cells in the bioreactor 100. Table 1 below provides a summary of gravitational acceleration influences along two axes, namely, the T and ĹĹ axes as shown in
For Table 1, a positive sign “+” indicates acceleration in the positive direction for the subject axis when the bioreactor is at the position or while rotating as shown in column 1; a negative sign “−” indicates acceleration in the negative direction for the subject axis when the bioreactor is at the position or while rotating as shown in column 1; and zero “0” indicates substantially no acceleration for the subject axis when the bioreactor is at the position as shown in column 1. Zero degrees (0°) is defined as the orientation of the bioreactor 100 when the longitudinal axis LA-LA is oriented horizontally with the EC inlet 128 and EC outlet 132 oriented upwards (as shown in
Accordingly, the impulse I is calculated as follows:
{right arrow over (I)}=m·{right arrow over (a)}·Δt, where m is the mass of the cell and Δt is the time for which the acceleration is applied.
IT=m·aT·Δt, where IT is the impulse in a direction traverse (“T”) to the longitudinal axis of the bioreactor.
IĹĹ=m·aĹĹ·Δt, where IĹĹ is the impulse in the longitudinal direction (“ĹĹ”) (i.e., parallel to the longitudinal axis LA-LA) of the bioreactor.
Pause at 0°:
where aT,avg the average value of aT from 0° to 90°, and where ω is the radial velocity (degrees/second)
Alternatively,
this will also be me same for rotation from 90° to 0°.
Rotation from 90° to 180°:
Again, these win De the same as for 180° to 90°
Rotation from 180° to 270°
Pause at 270°:
IT=m·0·tp,270°, where tp, 270° is the pause time at 270°.
IĹĹ=m·g·tp,270 °
Desire ΣIT=0, sum IT column and set equal to 0 to solve for tp,0°.
Desire ΣIĹĹ=0, sum IĹĹ column and set equal to 0 to solve for tp,270°.
where ω is the constant angular velocity in radians/seconds
where ω is the constant angular velocity in radians/second
For current constant angular velocity of 60° per second,
In accordance with the foregoing calculations, a method of distributing cells in a bioreactor 100 includes manipulating the orientation of the bioreactor 100, such that a net impulse due to gravity acting on cells loaded into the bioreactor 100 is substantially zero. In accordance with at least one embodiment, the manipulation of the bioreactor comprises both rotating the bioreactor 100 and thereafter holding the bioreactor stationary for set periods of time. In accordance with at least one embodiment, the time for holding the bioreactor 100 stationary tp is approximately equal to the quantity 2ω−1, wherein the angular velocity ω (rad/sec) is substantially constant for the periods when the bioreactor 100 is undergoing rotation. As those skilled in the art will appreciate, different angular velocities and pause times can be used.
Referring again to
As those skilled in the art will appreciate, more than one rotational direction is possible. In addition, more than one initial starting position is also possible provided a balancing of the influence of gravity on the cells loaded into the bioreactor 100 is achieved. Accordingly, the calculations, examples and discussion herein provide one or more possible configurations for manipulating the bioreactor 100 to reduce, minimize or eliminate the influence of gravity on cells and improve distribution of cells within the bioreactor. However, to the extent that other embodiments and variations are encompassed by the present disclosure, the calculations, description and figures are to be considered exemplary and non-limiting.
In accordance with at least one embodiment, the influence of gravity on cell distribution in the bioreactor 100 is controlled by the angular velocity applied to the bioreactor 100. More particularly, the rotational or angular velocity ω (rad/sec) is used to balance the net impulse due to gravity experienced by cells within the bioreactor 100. By way of example and not limitation, the bioreactor 100 is rotated as summarized below in Table 3.
In the sequence of rotations summarized in Table 3, the bioreactor 100 is rotated from −45° to 225° and back, with the bioreactor 100 paused for a time tp at both −45° and 225°. More particularly, the bioreactor 100 is rotated from −45° to 0° at a rotational velocity ω1, and from 0° to 180° at a rotational velocity ω2. The bioreactor 100 is then rotated from 180° to 225° at rotational velocity ω1 and then paused for a prescribed time interval at 225°. After pausing at 225° the steps are reversed. Accordingly, from 225° to 180° the bioreactor 100 is rotated at rotational velocity ω1. Thereafter, the bioreactor 100 is rotated from 180° to 0° at a rotational velocity of ω2, and from 0° to −45° at a rotational velocity ω1. For this embodiment, ω2 can be determined as a function of tp and ω1:
ω2=4/((2/20.5·tp)+(4/ω1)·((20.5−1)/20.5))
As an example:
if tp=1 sec, and ω1=30°/sec or π/6 rad/sec,
then ω2=62.74°/sec or 1.095 rad/sec.
For the example directly above, it is observed that ω2 is approximately twice ω1.
As those skilled in the art will appreciate, the above-provided equation allows for solving for ω2 when tp=0 and ω1 is a known quantity. Accordingly, in at least one embodiment, a method of reducing a net impulse due to gravity acting on cells loaded into a bioreactor is provided, wherein a pause time of substantially zero is possible and the relationship of the angular velocities is described as:
ω2=4/((4/ω1)·((20.5−1)/20.5))
In addition to the foregoing, upon reviewing the intervals of application of the different angular velocities shown in Table 3, it can be seen that ω2 is applied for approximately 360° degrees of angular displacement, while ω1 is applied for half that, or approximately 180° of angular displacement.
In accordance with at least one embodiment, a method of distributing cells within a bioreactor 100 having a longitudinal axis LA-LA includes: initiating the loading and distributing of cells into the bioreactor 100 when the longitudinal axis LA-LA is substantially horizontal or angled at about 45° relative to horizontal; rotating the bioreactor 100 through a total of approximately 540° of angular displacement; and holding the bioreactor 100 still at a plurality of orientations. In at least one embodiment, the angular velocity of rotation is substantially the same for those intervals of time wherein the bioreactor is rotating. In at least one embodiment, the angular velocity of rotation of the bioreactor 100 is changed from a first angular velocity ω1 to a second angular velocity ω2 for portions of the time the bioreactor 100 is undergoing rotation.
Referring now to
With reference now to
In at least one embodiment, cells are loaded and distributed throughout the bioreactor 100 during a loading and distribution step that operates for greater than about 2 minutes of time. In at least one embodiment the loading and distribution step may operate for several minutes. During the loading and distribution step the bioreactor 100 undergoes a plurality of rotational sequences that are undertaken consecutively from the time loading of the cells is commenced until such time as substantially all of the cells have been loaded into the bioreactor 100 and its associated tubing.
In at least one embodiment, a bioreactor 100 is loaded with a plurality of cells while undergoing rotation such that a net impulse due to gravity acting on the plurality of cells is reduced relative to a net impulse due to gravity acting on the plurality of cells if the bioreactor 100 was not undergoing rotation. That is, the method comprises manipulating an orientation of the bioreactor such that an actual net impulse due to gravity acting on the plurality cells in the bioreactor is reduced relative to an avoided net impulse due to gravity acting on the plurality cells if the bioreactor was held in a stationary position.
In at least one embodiment, the bioreactor 100 is rotated through at least 180° of rotation to reduce the net impulse of gravity acting on the plurality of cells.
In at least one embodiment, the bioreactor 100 is rotated in a pitch mode to reduce the net impulse due to gravity acting on the plurality of cells, wherein an axis of rotation is oriented transversely to a longitudinal axis LA-LA of the bioreactor 100. In at least one embodiment, the bioreactor 100 is rotated in a roll mode to reduce the net impulse due to gravity acting on the plurality of cells, wherein an axis of rotation is oriented substantially parallel to a longitudinal axis LA-LA of the bioreactor 100. Here, the axis of rotation that is substantially parallel to the longitudinal axis LA-LA may be coincident with the longitudinal axis LA-LA.
In at least one embodiment, harvesting of cells from the bioreactor 100 is performed by manipulating the orientation of the bioreactor 100 as described herein. That is, the bioreactor 100 is rotated to reduce a net impulse due to gravity acting on the cells during the harvesting procedure. Such manipulation of the bioreactor during cell harvesting improves the collection efficiency of cells. In addition, such manipulation of the bioreactor during cell harvesting also improves the number of cells collected because the influence of gravity is overcome as the cells are washed from the bioreactor 100.
In at least one embodiment wherein cells are grown in a suspension and not adhered to the walls of hollow fibers in the bioreactor, the bioreactor can be continuously manipulated to reduce the influence due to gravity on cells residing with the bioreactor.
Various components may be referred to herein as “operably associated.” As used herein, “operably associated” refers to components that are linked together in operable fashion, and encompasses embodiments in which components are linked directly, as well as embodiments in which additional components are placed between the two linked components.
The one or more present inventions may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.
The one or more present inventions, in various embodiments, include components, methods, processes, systems and/or apparatus substantially as depicted and described herein, including various embodiments, subcombinations, and subsets thereof. Those of skill in the art will understand how to make and use the present invention after understanding the present disclosure.
The one or more present inventions, in various embodiments, include providing devices and processes in the absence of items not depicted and/or described herein or in various embodiments hereof, including in the absence of such items as may have been used in previous devices or processes (e.g., for improving performance, achieving ease and/or reducing cost of implementation).
The foregoing discussion of the one or more present inventions has been presented for purposes of illustration and description. The foregoing is not intended to limit the one or more present inventions to the form or forms disclosed herein. In the foregoing Detailed Description for example, various features of the one or more present inventions are grouped together in one or more embodiments for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the claimed invention requires more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive aspects lie in less than all features of a single foregoing disclosed embodiment. Thus, the following claims are hereby incorporated into this Detailed Description, with each claim standing on its own as a separate preferred embodiment of the one or more present inventions.
Moreover, though the description of the one or more present inventions has included description of one or more embodiments and certain variations and modifications, other variations and modifications are within the scope of the invention (e.g., as may be within the skill and knowledge of those in the art, after understanding the present disclosure). It is intended to obtain rights which include alternative embodiments to the extent permitted, including alternate, interchangeable and/or equivalent structures, functions, ranges or steps to those claimed, whether or not such alternate, interchangeable and/or equivalent structures, functions, ranges or steps are disclosed herein, and without intending to publicly dedicate any patentable subject matter.
The present application claims the benefit of U.S. Patent Provisional Patent Application Ser. No. 61/290,629 filed on Dec. 29, 2009, the contents of which are incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3821087 | Knazek et al. | Jun 1974 | A |
4391912 | Yoshida et al. | Jul 1983 | A |
4647539 | Bach | Mar 1987 | A |
4804628 | Cracauer et al. | Feb 1989 | A |
4885087 | Kopf | Dec 1989 | A |
4889812 | Guinn et al. | Dec 1989 | A |
4918019 | Guinn | Apr 1990 | A |
5126238 | Gebhard et al. | Jun 1992 | A |
5162225 | Sager et al. | Nov 1992 | A |
5202254 | Amiot et al. | Apr 1993 | A |
5416022 | Amiot | May 1995 | A |
5459069 | Palsson et al. | Oct 1995 | A |
5605822 | Emerson et al. | Feb 1997 | A |
5622857 | Goffe | Apr 1997 | A |
5656421 | Gebhard et al. | Aug 1997 | A |
5688687 | Palsson et al. | Nov 1997 | A |
5763261 | Gruenberg | Jun 1998 | A |
5763266 | Palsson et al. | Jun 1998 | A |
5882918 | Goffe | Mar 1999 | A |
5888807 | Palsson et al. | Mar 1999 | A |
5958763 | Goffe | Sep 1999 | A |
5985653 | Armstrong et al. | Nov 1999 | A |
5994129 | Armstrong et al. | Nov 1999 | A |
5998184 | Shi | Dec 1999 | A |
6001585 | Gramer | Dec 1999 | A |
6048721 | Armstrong et al. | Apr 2000 | A |
6096532 | Armstrong et al. | Aug 2000 | A |
6228635 | Armstrong et al. | May 2001 | B1 |
6238908 | Armstrong et al. | May 2001 | B1 |
6566126 | Cadwell | May 2003 | B2 |
6582955 | Martinez et al. | Jun 2003 | B2 |
6642019 | Anderson et al. | Nov 2003 | B1 |
6844187 | Wechsler et al. | Jan 2005 | B1 |
6943008 | Ma | Sep 2005 | B1 |
6979308 | MacDonald et al. | Dec 2005 | B1 |
7041493 | Rao | May 2006 | B2 |
7112441 | Uemura et al. | Sep 2006 | B2 |
7172696 | Martinez et al. | Feb 2007 | B1 |
7270996 | Cannon et al. | Sep 2007 | B2 |
7531351 | Marx et al. | May 2009 | B2 |
7718430 | Antwiler | May 2010 | B2 |
20040027914 | Vrane | Feb 2004 | A1 |
20060019388 | Hutmacher et al. | Jan 2006 | A1 |
20060019391 | Marx et al. | Jan 2006 | A1 |
20070122904 | Nordon | May 2007 | A1 |
20070231305 | Noll et al. | Oct 2007 | A1 |
20070298497 | Antwiler | Dec 2007 | A1 |
20080220522 | Antwiler | Sep 2008 | A1 |
20080220523 | Antwiler | Sep 2008 | A1 |
20080248572 | Antwiler | Oct 2008 | A1 |
20080254533 | Antwiler | Oct 2008 | A1 |
20100042260 | Antwiler | Feb 2010 | A1 |
20100105138 | Dodd et al. | Apr 2010 | A1 |
20100144037 | Antwiler | Jun 2010 | A1 |
20100210016 | Leuthaeuser et al. | Aug 2010 | A1 |
Number | Date | Country |
---|---|---|
0220650 | May 1987 | EP |
1277544 | Jun 1972 | GB |
8602379 | Apr 1986 | WO |
9002171 | Mar 1990 | WO |
9504813 | Feb 1995 | WO |
9521911 | Aug 1995 | WO |
9716527 | May 1997 | WO |
9853046 | Nov 1998 | WO |
0075275 | Dec 2000 | WO |
2004090112 | Oct 2004 | WO |
2007136821 | Nov 2007 | WO |
2007139742 | Dec 2007 | WO |
2007139746 | Dec 2007 | WO |
2007139747 | Dec 2007 | WO |
2007139748 | Dec 2007 | WO |
2008109674 | Sep 2008 | WO |
2008128165 | Oct 2008 | WO |
2009034186 | Mar 2009 | WO |
Entry |
---|
Hoson et al., Evaluation of the three-dimensional clinostat as a simulator of weightlessness, 1997, Planta 203(1): S187-S197 (1997). |
Infanger et al., Simulated weightlessness changes the cytoskeleton and extracellular matrix proteins in papillary thyroid carcinoma cells, 2006, Cell and Tissue Research 324(2): 267-277. |
International Search Report and Written Opinion issued Dec. 5, 2011 in Application No. PCT/US2010/060409 (PG0203-W001). |
Chang et al, “Membrane Bioreactors: Present and Prospects”, Advances in Biochemical Engineering, 1991, 44:27-64. |
Chang, Ho Nam, “Membrane Bioreactors: Engineering Aspects”, Biotech. Adv., 1987, vol. 5, pp. 129-145. |
Edgington, Stephen M., “New Horizons for Stem-Cell Bioreactors”, Biotechnology, v. 10, Oct. 1992, pp. 1099-1106. |
Gastens et al, “Good Manufacturing Practice-Compliant Expansion of marrow-Derived Stem and Progenitor Cells for Cell Therapy”, Cell Transplantation, 2007 vol. 16, pp. 685-696. |
Gramer et al, “Screening Tool for Hollow-Fiber bioreactor Process Development”, Biotechnol. Prog., 1998, 14, 203-209. |
Hirschel et al, “An Automated Hollow Fiber System for the large Scale manufacture of mammalian Cell Secreted Product”, in Large Scale Cell Culture Technology, ed. Bjorn K. Lydersen, Hanser Publishers, 1987, pp. 113-144. |
Nielsen, Lars Keld, “Bioreactors for Hematopoietic Cell Culture”, Annu. Rev. Biomed. Eng., 1999,1:129-152. |
Pörtner et al, “An Overview on Bioreactor Design, Prototyping and Process Control for Reproducible Three-Dimensional Tissue Culture”, in Drug Testing in Vitro: Breakthroughs and trends in Cell Culture Technology, ed. Uwe Marx and Volker Sandig, Wiley-VCH, 2007, Chapter 2, pp. 53-78. |
Zhao et al, “Perfusion Bioreactor System for Human Mesenchymal Stem Cell Tissue Engineering: Dynamic Cell Seeding and Construct Development”, Biotechnology and Bioengineering, vol. 91, No. 4, Aug. 20, 2005, pp. 482-493. |
Number | Date | Country | |
---|---|---|---|
20110159584 A1 | Jun 2011 | US |
Number | Date | Country | |
---|---|---|---|
61290629 | Dec 2009 | US |